课题基金 / 基金详情

Targeting HSP90 in prostate cancer bone microenvironment by using a novel inhibitor: SNX-5422

Targeting HSP90 in prostate cancer bone microenvironment by using a novel inhibitor: SNX-5422
使用新型抑制剂：SNX-5422 靶向前列腺癌骨微环境中的 HSP90
批准号：
203479
负责人：
Lamoureux Francois
金额：
$3.28万
依托单位：
Vancouver Coastal Health Research Institute
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-02-01 至 2011-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=203479&lang=en
关键词：
Bone Metastasis Cell Biology Heat Shock Protein Hsp90 Inhibitor Pre-Clinical Model Prostate Cancer Therapeutic Approach Tumor Bone Microenvironment

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The prostate cancer is the most common cancer in men and is the second leading cause of cancer death in men after lung cancer. In more than 80% of cases, the prostate cancer is associated with the development of bone metastases responsible for bone pain a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金